Exploring trends in vision-threatening diabetic retinopathy over two decades

Published on May 19, 2026
Advancements in diabetes management and screening have had a “tremendous impact” on the risk of progressing to sight-threatening disease
Continue reading on website
Other news

PECAA Launches Promise Customer Brand Contact Lenses to Support Profitability and Patient Loyalty for Doctors

May 19, 2026
BOCA RATON, Fla.—Professional Eye Care Associates of America (PECAA) has launched PECAA promise, a portfolio of private label 1-day contact lenses that includes PECAA promise 1 day and PECAA promise 1 day premium, both available to PECAA Max members beginning June 1, 2026. The lenses were initially announced earlier this week on the first day of PECAA’s annual meeting. The launch aligns with PECA

Study Finds Clobetasol Effective for Treating Post-Cataract Inflammation, Discomfort

May 20, 2026
Both Phase III trials for clobetasol propionate ophthalmic suspension 0.05% (Byqlovi, Harrow) demonstrate the drop’s ability to reduce ocular inflammation and pain and improve visual acuity. Its short treatment duration—twice-daily dosing for two weeks—may make it particularly advantageous for elderly patients, researchers suggest. Photo: Harrow. Click image to enlarge. In s